News

Silence Therapeutics presents additional data from phase 1 study of divesiran as potential first-in-class siRNA treatment for polycythemia vera: London Monday, June 16, 2025, 18:0 ...
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that ...
Tabelecleucel shows promising efficacy in treating EBV-positive PTLD, offering hope for patients resistant to previous ...
Traditional cancer therapies aim to destroy tumor cells, often damaging nearby healthy tissue and triggering harsh side ...
Too much sun exposure can sometimes go beyond just an unpleasant sunburn. It also can lead to sun poisoning. While a sunburn will cause red, painful skin, sun poisoning is a severe type of ...
[40] Likewise, loss of blood pressure regulation should not occur if a dose is missed. Irbesartan is available as a single-ingredient product and in combination with hydrochlorothiazide (Avalide ...
These drugs are both used to treat high blood pressure and reduce the risk of heart-related problems like heart attacks, ...
Nearly half of all adults in the United States have either prediabetes or diabetes, according to the CDC, and many others without the conditions have started monitoring their glucose levels. Unmanaged ...